| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 7,300 | 7,350 | 15:33 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.10. | Attendo is changing its distribution channel for press releases | 3 | Cision News | ||
| 27.10. | Attendo AB: Attendo files claim against the city of Västerås after incorrect termination of home care contract | 165 | GlobeNewswire (Europe) | Attendo's view is that the City of Västerås had no basis for the termination of the home care agreement that occurred earlier this year. Attendo has also been informed that the preliminary investigations... ► Artikel lesen | |
| ATTENDO Aktie jetzt für 0€ handeln | |||||
| 27.10. | Attendo AB: Attendo divests its child welfare and family care operations in Finland | 225 | GlobeNewswire (Europe) | Attendo and Validia have signed an agreement whereby Attendo will divest its childcare and family care operations in Finland, with Validia as the new owner. The transaction is expected to close in the... ► Artikel lesen | |
| 27.10. | Ambea, through its Finnish business area Validia, has entered into an agreement to acquire Attendo's child welfare and family care services in Finland | 1 | Cision News | ||
| 24.10. | Attendo AB: Attendo's interim report for July-September 2025: The strongest quarter to date, driven by the development in Finland | 109 | GlobeNewswire (Europe) | Developments continued to be positive during the third quarter of the year, primarily driven by the Finnish operations and increased occupancy in nursing homes in both Finland and Scandinavia. The strong... ► Artikel lesen | |
| 23.09. | ATTENDO: Repurchases of shares during week 38, 2025 | 1 | Cision News | ||
| 18.09. | Attendo terminates Home Care contracts in Katrineholm and Nyköping | 2 | Cision News | ||
| 16.09. | ATTENDO: Repurchases of shares during week 37, 2025 | 1 | Cision News | ||
| 15.09. | Attendo has completed the acquisition of Främja AB - grows within LSS under the Unika brand | 1 | Cision News | ||
| 09.09. | ATTENDO: Repurchases of shares during week 36, 2025 | 3 | Cision News | ||
| 02.09. | ATTENDO: Repurchases of shares during week 35, 2025 | 1 | Cision News | ||
| 26.08. | ATTENDO: Repurchases of shares during week 34, 2025 | 2 | Cision News | ||
| 19.08. | ATTENDO: Repurchases of shares during week 33, 2025 | 1 | Cision News | ||
| 12.08. | ATTENDO: Repurchases of shares during week 32, 2025 | 1 | Cision News | ||
| 05.08. | ATTENDO: Repurchases of shares during week 31, 2025 | 1 | Cision News | ||
| 29.07. | ATTENDO: Repurchases of shares during week 29 & 30, 2025 | 1 | Cision News | ||
| 18.07. | Attendo AB: Attendo's Report For April-june 2025: Strong Quarter With Continued Earnings Growth | 384 | GlobeNewswire (Europe) | Attendo reports continued earnings growth, strong cash flow and high satisfaction among customers and employees in the second quarter of 2025. The results are mainly driven by the Finnish operations... ► Artikel lesen | |
| 17.07. | Attendo to buy back shares for a maximum amount of SEK 150 million | 3 | Cision News | ||
| 04.07. | Attendo's interim report for April-June 2025 to be published on 18 July - Invitation to presentation | 2 | Cision News | ||
| 25.06. | Attendo grows within LSS and the Unika brand - acquires Främja AB | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 20,110 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,960 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| BETA BIONICS | 29,720 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 47,740 | -1,57 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,350 | +0,95 % | FMC, Hugo Boss, Kontron, PVA TePla, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,760 | +0,86 % | Aktien Frankfurt Ausblick: Dax dürfte vor US-Zinsentscheidung leicht schwächeln | FRANKFURT (dpa-AFX) - Vor der US-Leitzinsentscheidung an diesem Abend dürften die Anleger am deutschen Aktienmarkt einen Gang herunterschalten. Der Dax wurde rund eine Stunde vor Beginn des Börsenhandels... ► Artikel lesen | |
| CERIBELL | 21,900 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 36,120 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| PROGYNY | 26,360 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,890 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| HEARTBEAM | 2,630 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| GENEDX | 150,62 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| QUIPT HOME MEDICAL | 3,500 | +34,10 % | Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management | Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,380 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,100 | -0,05 % | Carl Zeiss Meditec: Ein Top-Turnaroundkandidat für 2026! | Die Aktie des Medizingeräteherstellers Carl Zeiss Meditec blickt auf ein schwaches Börsenjahr zurück. Doch schon das kommende Jahr könnte die Wende bringen. Carl Zeiss Meditec: Ein Underperformer vor... ► Artikel lesen |